Allison Rosenzweig PhD

Rosenzweig is the scientific communications manager, working on written materials for the website, emails and other communications about biomedical research taking place from PanCAN grants and in the field in general. Her main focus is on providing lay-level descriptions of pancreatic cancer research news, including laboratory science and clinical results. “I love being able to make science interesting, understandable and relevant to all of our constituents. I was particularly proud of our team’s efforts to write about a very exciting recent drug approval – Keytruda was approved to treat any solid tumor, including pancreatic, with specific molecular alterations. Our summary of this news and its context led to patients and family members contacting Patient Central, inquiring about our Know Your Tumor® precision medicine service and determining their eligibility for Keytruda or other targeted therapies.” Rosenzweig holds a PhD in cellular & molecular biology from the University of Michigan. Her BS is in molecular biology from University of California, San Diego.